The Lovely Meds Journal

Wellness worth understanding.

Clear, evidence-based guidance on modern health from the licensed U.S. clinicians and pharmacists behind Lovely Meds. No hype, no jargon, just what the science says and what it means for you.

Featured
Latest

From the Journal

Important Safety Information

Indication. Compounded semaglutide and tirzepatide are GLP-1 (and GLP-1/GIP) medications that a licensed physician may prescribe for chronic weight management when clinically appropriate, alongside a reduced-calorie diet and increased physical activity.

Common side effects. The most commonly reported side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion and fatigue. These are often mild and tend to ease over time.

Warnings. These medicines may cause serious side effects, including possible thyroid tumors. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your provider about any history of pancreatitis, gallbladder disease, kidney problems, or if you are pregnant, planning to become pregnant, or breastfeeding.

Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.

Why trust Lovely Meds

Care you can stand behind

Board-Certified Clinicians Licensed U.S. medical team
503A Licensed Pharmacies Substance-specific approval
HIPAA Compliant Your data stays private
Ready when you are

Talk to a Lovely Meds clinician

An independent, licensed medical professional will review your online evaluation and determine whether treatment is appropriate for you.

Start a free consultation